好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2019 Annual Meeting | C85 - Severe TBI: From ICU to Rehabilitation

Monday 05/06/19
07:00 AM - 09:00 AM EDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Susanne Muehlschlegel, MD, MPH, FAAN
Aging, Dementia, and Behavioral Neurology, Neuro Trauma, Critical Care, and Sports Neurology, Neuro-rehabilitation
Participants should be familiar with the variety of pathophysiologic mechanisms associated with TBI and how to prevent or minimize secondary brain injury with up-to-date acute management recommendations emphasizing relevant guidelines; be comfortable using clinical information and imaging techniques to aid in prognostication after severe TBI; and understand state-of-the art rehabilitation approaches after severe TBI.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Intermediate
Neurohospitalist
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM EDT Introduction Introduction
Susanne Muehlschlegel, MD, MPH, FAAN
07:05 AM - 07:40 AM EDT Speaker ICU management and Prognosis in the ICU
Susanne Muehlschlegel, MD, MPH, FAAN
07:40 AM - 08:20 AM EDT Speaker Imaging in Severe TBI
Brian Edlow, MD
08:20 AM - 09:00 AM EDT Speaker Rehabilitation in Severe TBI: Current Approaches and Ongoing Research
Kristen Dams-O'Connor, PhD
Faculty Disclosures
Susanne Muehlschlegel, MD, MPH, FAAN Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acasti Pharma Inc.. Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti Pharma Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from Johns Hopkins Stimulating and Advancing Anesthesiology & Critical Care Medicine Research (StAAR) Award. The institution of Dr. Muehlschlegel has received research support from Trustees of The Patrick and Catherine Weldon Donaghue Medical Research Foundation. The institution of Dr. Muehlschlegel has received research support from Harkin Family Fund (Johns Hopkins Dept. of Neurology). Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Speaker and Author with 好色先生. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
Brian Edlow, MD Dr. Edlow has received research support from NIH.
Kristen Dams-O'Connor, PhD Dr. Dams-O'Connor has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Dams-O'Connor has received research support from NIH. The institution of Dr. Dams-O'Connor has received research support from Department of Defense. The institution of Dr. Dams-O'Connor has received research support from National Institute on Disability Independent Living and Rehabilitation Research. The institution of Dr. Dams-O'Connor has received research support from Patient Reported Outcomes Research Institute.